Shinji Takamatsu

9PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersGlycoconjugatesMolecular targetsMedical biochemistry - lipidsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 02, 2026
Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All-Cause Mortality After SVR in Advanced Chronic Hepatitis C.

|Sep 27, 2025
Potential for Core Fucose-Targeted Therapy Against HBV Infection of Human Normal Hepatocytes.

Shinji Takamatsu, Chiharu Morita, Daisuke Sakon

|Sep 28, 2024
Development of a FUT8 Inhibitor with Cellular Inhibitory Properties.

Yoshiyuki Manabe, Tomoyuki Takebe, Satomi Kasahara

|Sep 09, 2024
Core-fucose-specific Pholiota squarrosa lectin decreased hepatic inflammatory macrophage infiltration in steatohepatitis mice.

Yoshihiro Kamada, Yui Ueda, Eriko Matsuno

|Apr 28, 2023
Vesicular Integral-Membrane Protein 36 Is Involved in the Selective Secretion of Fucosylated Proteins into Bile Duct-like Structures in HepG2 Cells.

Mizuki Muranaka, Shinji Takamatsu, Tsunenori Ouchida

|Aug 15, 2022
Lewis glycosphingolipids as critical determinants of TRAIL sensitivity in cancer cells.

Tomoya Fukuoka, Kenta Moriwaki, Shinji Takamatsu

Pageof 2

Frequent Collaborators

8 joint publications

Eiji Miyoshi

3 joint publications

Jumpei Kondo

3 joint publications

Yoshihiro Kamada

2 joint publications

Kenta Moriwaki